全球黄斑变性治疗市场，按类型（湿性黄斑变性、干性黄斑变性）、治疗（药物、手术）、给药途径（口服、注射和其他）、最终用户（医院、家庭护理、专科诊所、眼科诊所和其他）、分销渠道（医院药房、零售药房、网上药房）、国家（美国、加拿大、墨西哥、巴西、阿根廷、秘鲁、南美洲其他地区、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、越南、亚太其他地区、沙特阿拉伯、阿联酋、埃及、以色列、科威特、南非、中东和非洲其他地区）行业趋势和预测到 2028 年
市场分析与洞察：全球黄斑变性治疗市场
预计黄斑变性治疗市场将在 2021-2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在上述预测期内，市场复合年增长率为 6.80%，预计到 2028 年将达到 131.0805 亿美元。
黄斑变性是一种神经退行性眼部疾病，会影响眼睛的黄斑部分。黄斑变性会导致中央视力丧失，因为中央视力是清晰看清物体所必需的，而黄斑提供清晰的中央视力。当中央凹周围的毛细血管扩张和渗漏时，就会发生黄斑变性。这会导致液体积聚，影响光线的反射，并导致视力逐渐丧失。它主要影响 50 至 60 岁的人。这种疾病的特点是夜盲症、管状视野和中央视力丧失。它也被称为老年性黄斑变性 (AMD)。
眼表损伤发生率上升（因为它可能导致神经营养性角膜炎）和先进疗法的发展是影响市场增长的主要因素。此外，对研究人员开发新干预措施的巨额资金支持、监管机构的特殊指定增加以及可以改善视力的细胞疗法的进步是扩大黄斑变性治疗市场的因素。
对新型治疗方法的需求不断增长以及对研发活动的巨大投入将为 2021-2028 年预测期内的黄斑变性治疗市场提供有利的机会。
However, low healthcare budget in the developing countries and high cost associated with the treatment are the factors that will hinder the market growth. Surgical treatment may alter the appearance and function of the eye will challenge the Macular degeneration treatment market in the forecast period mentioned above.
This Macular degeneration treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Macular degeneration treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Macular Degeneration Treatment Market Scope and Market Size
The Macular degeneration treatment market is segmented on the basis of type, treatment, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the Macular degeneration treatment market is segmented into wet macular degeneration and dry macular degeneration.
- On the basis of treatment, the Macular degeneration treatment market is segmented into drugs and surgery. Drugs have been further sub-segmented into ranibizumab, aflibercept and others. Surgery has been further sub-segmented into laser photocoagulation surgery and subretinal surgery.
- On the basis of route of administration, the Macular degeneration treatment market is segmented into oral, injectable and others.
- On the basis of end-users, the Macular degeneration treatment market is segmented into hospitals, homecare, specialty clinics, ophthalmic clinic and others.
- The Macular degeneration treatment market is also segmented on the basis of distribution channel into hospital pharmacies, retail pharmacies and online pharmacies.
Macular Degeneration Treatment Market Country Level Analysis
Macular degeneration treatment market is analyzed and market size information is provided by the country, type, treatment, route of administration, end-users and distribution channel as referenced above.
The countries covered in the Macular degeneration treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
North America dominates the Macular degeneration treatment market due to the presence of major key players, rise in the prevalence of eye disorders, increasing geriatric population, favourable reimbursement policies and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the rise in the prevalence macular degeneration, surge in the investment for healthcare sector, growing awareness and increase in the disposable income.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Macular degeneration treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Global Macular Degeneration Treatment Market Share Analysis
Macular degeneration treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to macular degeneration treatment market research.
黄斑变性治疗市场报告中涉及的主要参与者包括 Adverum Biotechnologies Inc.、Neurotech、Gilead Sciences, Inc.、F. Hoffmann-La Roche Ltd、Allergan、Regeneron Pharmaceuticals, Inc、STEMCELL Technologies Inc、IVERIC bio, Inc.、SANWA KAGAKU KENKYUSHO CO.,LTD.、Bausch Health Companies Inc.、Alcon Vision LLC、Phio Therapeutics Corp.、Kubota Pharmaceutical Holdings Co., Ltd、Bayer AG、Novartis AG、Opthea、Santen Pharmaceutical Co., Ltd、PanOptica, Inc 和 Resolvyx Pharmaceuticals, Inc，以及其他国内和全球参与者。市场份额数据分别针对全球、北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 和南美提供。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
